Rheumatoid arthritis in the Kingdom of Saudi Arabia

被引：0
|
作者：
Merashli, Mira [1 ]
Jawad, Ali S. [1 ]
机构：
[1] Royal London Hosp, Dept Rheumatol, London E1 1BB, England
来源：
SAUDI MEDICAL JOURNAL | 2015年 / 36卷 / 05期
关键词：
D O I：
10.15537/smj.2015.5.11639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [1] OPTIMIZING TREATMENT FOR RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA (OPTRA)
    Almudaiheem, H. Y.
    Mohamed, O.
    Dawoud, D.
    Alsuwayeh, Y.
    Alenzi, K.
    Mughari, M.
    Alshaber, N.
    Mekwar, B.
    Prasanna, R.
    Awad, N.
    Alasmari, M.
    VALUE IN HEALTH, 2018, 21 : S291 - S291
  • [2] Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
    Khabsa, Joanne
    Yaacoub, Sally
    Omair, Mohammed A.
    Al Rayes, Hanan
    Akl, Elie A.
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [3] Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
    Joanne Khabsa
    Sally Yaacoub
    Mohammed A. Omair
    Hanan Al Rayes
    Elie A. Akl
    BMC Medical Research Methodology, 23
  • [4] Rheumatoid arthritis in Saudi Arabia
    Almoallim, Hani M.
    Alharbi, Laila A.
    SAUDI MEDICAL JOURNAL, 2014, 35 (12) : 1442 - 1454
  • [5] BUDGET IMPACT ANALYSIS OF GOLIMUMAB IN ADULT RHEUMATOID ARTHRITIS PATIENTS IN KINGDOM OF SAUDI ARABIA
    Al Jedai, A.
    AL-Mudaiheem, H.
    Pathak, P.
    Awad, N.
    Mohamed, O.
    Alghanim, N.
    Hussain, W.
    Qamar, A.
    Alama, T.
    VALUE IN HEALTH, 2019, 22 : S47 - S47
  • [6] BUDGET IMPACT ANALYSIS OF BARICITINIB FOR THE MANAGEMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA
    Almodaimegh, H.
    Alrumaih, A.
    Alabdulkarim, H. A. A.
    Alsaqa'aby, M.
    Alturaiki, A.
    Erdogan, A.
    Alhowimel, M.
    Alhammad, A.
    El Ojeil, R.
    Biswas, C.
    VALUE IN HEALTH, 2020, 23 : S412 - S412
  • [7] Prevalence of Hypertension and Its Associated Risk Factors Among Patients with Rheumatoid Arthritis in the Kingdom of Saudi Arabia
    Al-Ahmari, Abdullah K.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 6507 - 6517
  • [8] COST-EFFECTIVENESS ANALYSIS OF UPADACITINIB AS A TREATMENT OPTION FOR PATIENTS WITH RHEUMATOID ARTHRITIS IN KINGDOM OF SAUDI ARABIA
    Alabdulkarim, H.
    Almodaimegh, H.
    Abu Esba, L. C.
    Sharma, Y.
    Attar, S.
    Hussain, W.
    Alhomood, I
    Al-Omari, B. A.
    Mohamed, O.
    Alsaqa'aby, M.
    Roshdy, A.
    Anwar, A.
    Hamad, T.
    Alzahrani, Z.
    VALUE IN HEALTH, 2022, 25 (07) : S407 - S407
  • [9] Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia
    Al-Abdulkarim, Hana
    Sharma, Yuvraj
    Attar, Suzan M.
    Husain, Waleed
    Al-Homood, Ibrahim
    Al Omari, Bedor
    Mohamed, Omneya
    Alsaqa'aby, Mai
    Jaheen, Ahmed M.
    Anwar, Ali
    Hamad, Tharwat M.
    Alzahrani, Zeyad
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 134 - 144
  • [10] The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia
    Al-Dalaan, A
    Al Ballaa, S
    Bahabri, S
    Biyari, T
    Al Sukait, M
    Mousa, M
    ANNALS OF SAUDI MEDICINE, 1998, 18 (05) : 396 - 397
12345